CANDRIAM S.C.A. – Regeneron Pharmaceuticals, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$277.29M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +7.97% | 29.72K shares | 56.94M | $688.87 | 402.52K |
| Q2 2022 | share | Increase | +0.95% | 3.50K shares | -37.55M | $591.13 | 372.79K |
| Q1 2022 | share | Increase | +1.29% | 4.70K shares | 27.66M | $698.42 | 369.29K |
| Q4 2021 | share | Decrease | -6.19% | -24.05K shares | -4.94M | $642.51 | 364.58K |
| Q3 2021 | share | Decrease | -26.72% | -141.70K shares | -61.03M | $605.18 | 388.64K |
| Q2 2021 | share | Increase | +31.39% | 126.70K shares | 108.90M | $558.54 | 530.34K |
| Q1 2021 | share | Increase | 0.00% | 4 shares | -7.69M | $473.14 | 403.64K |
| Q4 2020 | share | Increase | +24.95% | 80.60K shares | 14.18M | $483.11 | 403.63K |
| Q3 2020 | share | Increase | +41.12% | 94.13K shares | 38.06M | $559.78 | 323.03K |
| Q2 2020 | share | Decrease | -44.34% | -182.31K shares | -8.17M | $623.65 | 228.90K |
| Q1 2020 | share | Increase | 0.00% | 5 shares | -3.46M | $488.29 | 411.21K |
| Q4 2019 | share | Decrease | -0.23% | -963 shares | 40.06M | $375.48 | 411.21K |
| Q3 2019 | share | Increase | +6.85% | 26.43K shares | -5.87M | $277.4 | 412.17K |
| Q2 2019 | share | Increase | +11.08% | 38.47K shares | -22.39M | $313 | 385.74K |
| Q1 2019 | share | Decrease | -0.60% | -2.08K shares | 12.12M | $410.62 | 347.27K |
| Q4 2018 | share | Increase | +0.86% | 2.97K shares | -9.47M | $373.5 | 349.35K |
| Q3 2018 | share | Increase | +83.68% | 157.8K shares | 74.89M | $404.04 | 346.38K |
| Q2 2018 | share | Increase | +45.49% | 58.96K shares | 20.42M | $344.99 | 188.58K |
| Q1 2018 | share | Increase | +7.04% | 8.52K shares | -888K | $344.36 | 129.62K |
| Q4 2017 | share | Decrease | -7.56% | -9.9K shares | -13.04M | $375.96 | 121.09K |
| Q3 2017 | share | Increase | +2.70% | 3.44K shares | -4.07M | $447.12 | 130.99K |
| Q2 2017 | share | Decrease | -25.29% | -43.18K shares | -3.51M | $491.14 | 127.54K |
| Q1 2017 | share | Increase | +58.30% | 62.87K shares | 26.57M | $387.51 | 170.72K |
| Q4 2016 | share | Increase | +1.54% | 1.63K shares | -3.11M | $367.09 | 107.84K |
| Q3 2016 | share | Increase | +11.68% | 11.10K shares | 9.48M | $402.02 | 106.21K |
| Q2 2016 | share | Increase | +34.03% | 24.14K shares | 7.77M | $349.23 | 95.10K |
| Q1 2016 | share | Decrease | -26.79% | -25.96K shares | -27.17M | $360.44 | 70.95K |